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Abstract: A higher incidence of diabetes was observed among family members of individuals affected
by Huntington’s Disease with no follow-up studies investigating the genetic nature of the observation.
Using a genome-wide association study (GWAS), RNA sequencing (RNA-Seq) analysis and western
blotting of Rattus norvegicus and human, we were able to identify that the gene family of sortilin
receptors was affected in Huntington’s Disease patients. We observed that less than 5% of SNPs were
of statistical significance and that sortilins and HLA/MHC gene expression or SNPs were associated
with mutant huntingtin (mHTT). These results suggest that ST14A cells derived from R. norvegicus
are a reliable model of HD, since sortilins were identified through analysis of the transcriptome in
these cells. These findings help highlight the genes involved in mechanisms targeted by diabetes
drugs, such as glucose transporters as well as proteins controlling insulin release related to mHTT.
To the best of our knowledge, this is the first GWAS using RNA-Seq data from both ST14A rat HD
cell model and human Huntington’s Disease.
Keywords: sortilins; diabetes; cancer; neurodegeneration; Huntington’s Disease; GWAS; RNA-seq;
ST14A cells; linkage; SORCS1; SORCS2; SORCS3; SORLA; SORT1; HLA; MHC
1. Introduction
1.1. Biology of Huntingtin and Identification of DNA Polymorphism Causing HD
Huntington’s disease (HD), a neurodegeneration characterized by motor, cognitive and psychiatric
symptoms is caused by an unstable expansion (CAG) in a polyglutamine (polyQ) tract in the N-terminal
of the huntingtin (HTT) gene. This condition is triggered when the number of CAG repeats on exon
1 of HTT exceeds 39, while 36-39 CAGs repeats result in an uncertain incidence of the disease [1].
Features of the genetic inheritance of CAG repeats in HTT were unknown for more than 200 years;
George Huntington described Huntington’s chorea in 1872 and linkage mapping of the genomic region
to HD occurred in 1993 [1,2]. HTT is highly conserved from flies to mammals and the N-terminal is
the most extensively studied region of the protein due to the CAG expansion on exon 1. HTT also
contains HEAT repeats which play an important role in protein-protein interactions. HEAT repeats
are a common helical motif in the Huntingtin protein, Elongation Factor 3, protein phosphatase 2A,
and TOR1 [3].
Tools such as the restriction fragment length polymorphism (RFLP) have been extensively used
in determining DNA polymorphisms of HTT inherited in HD families [4], but rarely used to study
other parts of the genome of HD individuals. RFLP was used in linkage disequilibrium studies that
characterized the genetic pattern of CAG repeats in HTT in HD families. The reason for the lack of
studies on the overall genome of HD individuals after characterization of mutant HTT is the assumption
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that no other genomic region influences human HD more than HTT. A study of SNPs in different parts
of the genome of HD individuals may help explain different genetic phenomena including increased
prevalence of diabetes among families affected with HD and cases where the CAG abnormal expansion
was not present in the father nor in the mother, but manifested in the descendants [5–7]. Due to the
great number of HTT molecular partners in events such as DNA and RNA metabolism, endocytosis,
subcellular trafficking and cellular homeostasis, genetic diversity of several proteins that interact with
HTT may affect prevalence these conditions among HD patients and their families.
Saudou and Humbert reviewed the interaction of HTT with proteins of the molecular motor
machinery such as dynein, dynactin and kinesin and the role of HEAT repeats allowing HTT to serve as
a scaffolding protein in these biological processes [8]. Zala et al., from the same group, found that the
HTT-dependent transport of GADPH, a gene from the glycolysis pathway, provides energy to sustain
the fast transport of vesicles using the cytoskeleton [9]. These studies support the notion that HTT acts
as a protein important in the transport of vesicles, also influencing cellular endocytosis and exocytosis.
1.2. Neurodegeneration and Metabolic Diseases
Endocytosis and exocytosis are cellular mechanisms that maintain the homeostasis of a cell and
play a direct role in neurodegenerations and metabolic diseases. Endocytosis and exocytosis influence
Type 1 Diabetes (T1D) and Type 2 Diabetes (T2D) in different ways. T1D or insulin-dependent diabetes,
features autoantibodies attacking proteins in the membrane of pancreatic cells. Problems in the
processing of antigens transported intracellularly by components such as phagosome, proteasome,
Golgi apparatus, ER, endosomes and the cell membrane are often associated with T1D. It has been
observed that glutamate decarboxylase, zinc transporter-8, IA-2, tetraspanin 7 and insulin act as
humoral autoantigens in T1D [10]. T2D, on the other hand, is characterized by a lack of response to
insulin in cells that need to use glucose, such as muscle cells, liver cells and adipocytes, even with the
production of the hormone in the pancreas. In cells of patients with T2D, glucose transporters and
proteins involved in the translocation of glucose transporters do not correctly respond to the insulin
signal. This results in a poor cellular uptake of glucose from the blood stream.
Among components involved in the translocation of glucose receptors to the cell membrane,
sortilins control sorting of proteins across different cellular compartments, including traffic between
the Golgi apparatus and the cellular membrane [11]. Translocation of insulin to the secretory pathway
following the release of the hormone in the blood stream is a cellular role performed with assistance of
sortilins [12]. The first report of mHTT affecting diabetes phenotypes was made in 1972, when a higher
prevalence of diabetes was detected among HD patients [6]. This observation was later supported
by findings indicating increased chances of diabetes among family members of individuals affected
with HD [7]. Since HTT is a scaffolding protein that connects cytoskeleton proteins to proteins of the
endocytosis and exocytosis pathways, it is possible that mutant mHTT affects diabetes phenotypes
related to these pathways.
1.3. VPS10P-Domain Receptors or Sortilins: Regulators of Subcellular Protein Trafficking and Markers of
Diabetes and Neurodegeneration
The vacuolar protein sorting 10 protein (VPS10P) domain is a 700-amino-acid motif first identified
in Saccharomyces cerevisiae that directs the trafficking of lysosomal enzymes from the Golgi apparatus
to the vacuole [13]. VPS10P-domain receptors in mammals contain five members; SORT1 (sortilin),
SORLA, SORCS1, SORCS2 and SORCS3. These receptors bind and neutralize a variety of ligands such
as trophic factors, neuropeptides, glucose receptor 4 (GLUT4) and the amyloid beta peptide between
the trans-Golgi network, the endosomes and the plasma-membrane [11,14–16]. In macrophages,
SORT1 binds other proteins from the Golgi apparatus causing the migration of vesicles using the
retromer complex. Vesicles containing sortilins end up fusing to the phagosome of macrophages and
are known to deliver specific proteins required for immunological control of Mycobacterium tuberculosis
by macrophages [17]. Due to its involvement with subcellular transport and signaling transduction,
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Reuter referred to SORT1 as a dual function protein. As a transduction protein, SORT1 controls the
translocation of epidermal growth factor ligands. As an intracellular protein transport controller,
SORT1 acts in antigen presentation in dendritic cells, illustrating the role of sortilin genes with the
immune system [18].
Considering the involvement of sortilin genes in immunity mediated by macrophages, sorting of
cellular proteins, as well as our previous study indicating the up-regulation of sortilin SORCS1 in a cell
model expressing mHTT [11,12,17–19], here focused on investigating the association of sortilins with
Huntington’s Disease using human and rat RNA-Seq datasets. We explore the involvement of sortilins
in an antigen presentation in HD and specifically provide evidence that proves sortilins are part of the
genetic component leading to diabetes in human HD.
2. Materials and Methods
2.1. Library Preparation and Sequencing
ST14A total RNA was extracted and converted to cDNA using the Smart-seq2 protocol [20]. cDNA
was then processed with the Nextera XT DNA library preparation kit according to the manufacturer’s
protocol (Illumina, San Diego, CA, USA). Libraries were purified and size-selected using the Nvigen
Size Selection Kit according to the manufacturer’s protocol [21]. The bioanalyzer 2100 high-sensitivity
DNA assay (Agilent, Santa Clara, CA, USA) was used to check on the size range. The functional library
concentration was determined with the KAPA Biosystems library quantification kit. The libraries were
denatured after quantification and loaded on Illumina HiSeq 2000 for sequencing.
2.2. Human and Rat GENOMES
We used the human genome assembly version GRCh37.p13 (hg19) available at the Ensembl
Genome Browser to align the human sequencing files analyzed in this study [22]. The Rattus norvegicus
reference genome version R_nor5.0 was used to map rat sequencing files [22]. Gene coordinates for
isolation of genetic variants using Unix commands and dbSNP IDs were also acquired using the
Ensembl Genome Browser website, when indicated.
2.3. Genome-Wide Association Study (GWAS)
The genome-wide association of RNA-Seq reads with Huntington’s disease was performed using
the costumer Unix/bash script disclosed by Mohammed Khalfan of the New York University Genetics
Core Facility [23]. Briefly, reads were aligned to the reference genome using BWA, sorted, converted
to a .BAM file, duplicate marked and indexed using Picard. The genome analyses toolkit (GATK)
developed and provided by the Broad Institute of Harvard and MIT was then used for realignment,
variant calling, single nucleotide polymorphism (SNP), indel filtering and extraction, base quality score
recalibration, and covariate analyses [24–26]. Knowing that GWAS strategies are relatively new in
science here we use the notion of GWAS as revised by Visscher: “GWAS is an experimental design used
to detect associations between genetic variants and traits in samples from populations”, to determine
that the algorithm used by this report represents the first GWAS using RNA-Seq data from the HD
cell model and human Huntington’s Disease [27]. Outputs of the GATK/GWAS pipeline were files
including the variant call format (.vcf), containing the SNPs identified for processing described and
reported in this document. A list of Unix commands used for analysis shown in this study are provided
in the Supplementary Materials.
2.4. Gene Expression Omnibus (GEO) RNA-Seq Datasets
We used GEO datasets previously published by Labadorf et al. (2015) (GEO accession number
GSE64810) [28], Lin et al. (2016) (GEO accession number GSM2100621) [29] and HD iPSC Consortium
(2017) (GEO accession number GSE95344) [30]. In this manuscript, we refer to these datasets as
Labadorf (2015), Lin (2016) and HD iPSC Consortium (2017) datasets respectively (publication year
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may or may not be indicated). Files .vcf and .count generated respectively by the GATK and DESeq2
pipelines are included in the Supplementary Materials (these files contain respectively the DNA genetic
variants and the read counts detected by these pipelines).
2.5. Post-GATK/GWAS Processing
Several processing steps were required after completion of the GATK/GWAS pipeline. These
steps were necessary to allow formatting of the output files for compliance with downstream
software requirements and were accomplished using Unix commands depicted in the Supplementary
Materials (this section includes a brief description of each Unix command used as well as extra results
supporting findings described in the main document). Other than the Unix commands depicted in the
Supplementary Materials, bcftools (version 1.9) [31], vcftools (version 0.1.14) [32] and (version 0.1.14)
Plink [33] were used to adjust the format of files used in the analysis. Plink was used for the extraction
of .ped and .map files.
2.6. Statistical Analysis
PLINK was used for statistical testing of the comparison cases versus controls. Fisher’s exact test
was calculated as depicted in the command shown in the Supplementary Materials to compare the
abundance of alleles in the cases and control individuals [33]. A p-value threshold of 0.05 was used to
consider a genetic variant statistically significant in our GATK/GWAS pipeline.
2.7. Manhattan Plots
R package Qqman was used to plot p-values below 0.05, indicating the association between HD and
the specific genetic variant detected in each genomic position, according to package instructions [34].
We highlighted SNPs located outside of the gene body up to 1,000,000 base-pairs upstream and
downstream of the gene body. We considered that within this region there existed regulatory elements
influencing the genetic products encoded by the gene body.
2.8. Linkage Visualization Using Haploview
PLINK was used to extract pedigree and .map files from .vcf files and to input Haploview using
default parameters, as determined by the Broad Institute guidelines in the website [23] and original
paper recommendations [35]. The haplotype block was determined using the Four Gametes Rule
option available on Haploview. Linkage plots were constructed with the standard LD color scheme
(D′/LOD). Color represents linkage, in the following order: red (LOD ≥ 2 and D′ = 1), pink (LOD ≥ 2
and D′ < 1), blue (LOD < 2 and D′ = 1), and white (LOD < 2 and D′ < 1).
2.9. Validation of GATK/GWAS DNA Variants Identification by Pyrosequencing
The NGS Pyrosequencing method was used as a genotyping validation of the GATK/GWAS
algorithm used in this study as previously described [36,37].
3. Results
3.1. mHTT Is Associated with SORCS1 Protein Up-Regulation and Sortilins SNPs
To investigate whether genetic variants of sortilin genes were associated with human HD,
we performed a GWAS in rat and human datasets using the Genome Analysis Tool Kit (GATK). Table 1
represents an overview of the significant SNPs detected in the entire RNA-Seq dataset as well as in the
sortilins gene body and vicinity.
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Table 1. Summary of SNP variants detected in rat and human through genome analysis
toolkit/genome-wide association study (RNA-Seq GATK/GWAS) pipeline. DNA variants identified in
the gene body and in regulatory vicinity regions are indicated.
Dataset Total Number ofSNPs Identified
Significant SNPs
(p < 0.05)
Sortilin Gene Body
Size (bp)
SNPs in
Gene Body
(p < 0.05)
SNPs in Vicinity (±106 bp
Away from Gene Body)
Rattus
norvegicus
(ST14A cells)
222997 8464 (3.80%)
SORCS1 499515 6 13
SORCS2 371129 0 8
SORCS3 641740 0 2
SORT1 89539 0 11
SORL1 170117 0 5
Labadorf 2658838 84349 (3.17%)
SORCS1 590871 2 8
SORCS2 550289 15 171
SORCS3 624134 4 53
SORT1 88381 9 153
SORL1 181490 4 38
Lin 3172675 44669 (1.4%)
SORCS1 590871 6 9
SORCS2 550289 10 121
SORCS3 624134 0 23
SORT1 88381 11 111
SORL1 181490 4 41
HD iPSC
Consortium
(iPSC Cells)
238013 8979 (3.38%)
SORCS1 590871 0 0
SORCS2 550289 0 20
SORCS3 624134 0 3
SORT1 88381 0 22
SORL1 181490 3 6
Based on the total number of SNPs identified, we were able to distinguish two groups of datasets;
those with low genetic variance and datasets with high genetic variance. It was observed that 220,000
Single Nucleotide Polymorphisms were significantly associated with mHTT in the ST14A and HD iPSC
Consortium data, whereas more than 2.6 million SNPs were significantly associated with mHTT in the
Labadorf and Lin datasets (Table 1). 1.4–3.8% of all SNPs detected were significant in each dataset and
this similarity indicates that variants were consistent across all groups that were analyzed.
We hypothesized that SNPs near the genes in the study could influence gene expression levels.
To substantiate our hypothesis, we counted the number of SNPs in the gene body and regulatory
regions. For this analysis, the gene regulatory region was defined as a body of±1,000,000 bp nucleotides
away from the gene body. We used a custom bash script to isolate the SNP positions (Supplementary
Material, Command 1A). In the ST14A rat dataset, only variants of the SORCS1 gene were identified
across the five possible sortilins (six SNPs in the gene body, 13 SNPs in the regulatory region) (Table 1).
For a better visualization of sortilins SNPs observed in the GATK/GWAS pipeline, a plot was developed
using the positions of the mutations relative to the sortilin gene organization and the dataset in which
SNPs were identified as shown in Figure 1.
From these results, it can be observed that sortilins had mutations significantly associated
with Huntington’s Disease (p-value < 0.05, Fisher’s exact test comparison) in the Labadorf dataset.
Only SORCS3 and Sortilin-related (SORL1) did not show mutations flanking introns two and three,
which are located between the exons encoding the VPS10P domain (Figure 1). For a list of all positions
of significant SNPs associated with HD in this study, see the Supplementary Materials PLINK output.
Figure 2A represents the agarose gel electrophoresis results. From the gel it is evident that
the SORCS1 protein levels were up-regulated in the mHTT-expressing cells, a phenomena that was
reported earlier by our group [19]. To further access the effect of mHTT on the biology of sortilins,
we investigated SNPs (Figure 2B) and the gene expression (Figure 2C) of sortilins associated with HD.
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Figure 1. Organization of sortilins genomic regions showing SNPs detected by the GWAS/GATK pipeline across introns and exons. The dataset of the identification is
indicated. (A) SORCS1 gene organization in R. norvegicus. (B) SORCS1 gene organization in human. (C) SORCS2 gene organization in human. (D) SORCS3 gene
organization in human. (E) SORT1 gene organization in human. (F) SORL1 gene organization in human. Mutations inside the red squares represent SNPs in introns
between exons that encode the VPS10P domain (Reitz 2013). Exons were indicated with their numbers in blue for identification.
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Labadorf et al. identified the expression of sortilins affected in HD individuals [28]. We believe
that the HD iPSC Consortium dataset did not share common SNPs with the Labadorf and Lin datasets
because the HD iPSC Consortium dataset was composed of “HD patient-derived iPSC lines with
juvenile-onset CAG repeat expansions (60 and 109 repeats)” [30], a more genetically homogeneous
group than the Labadorf and Lin datasets (Figure 2B). Further confirming our observations and those
of the Labadorf group gene expression of sortilins are influenced by mHTT in the HD iPSC Consortium
dataset (Figure 2C). Supplementary Table S1 shows the description of SNPs that were found significant
across all human datasets (p-value < 0.05, Fisher’s exact test). Among the biological processes reported
on the Supplementary Table S1, tetraspanin variants (illustrated in bold on Supplementary Table S1)
indicate the association of mHTT with the four-transmembrane proteins. In the ST14A rat cells that
we studied previously and here, the top up-regulated gene was TSPAN8, a transmembrane protein
responsible for the organization of the HLA/MHC complex. This observation indicates the agreement
between the findings concerning tetraspanins in the human and rat datasets analyzed in this study.
To compare the distribution of SNPs identified near the sortilin regions in the GATK/GWAS
pipeline exploited in this study with the overall SNPs flanking other genes, Manhattan plots were
constructed with the significant (p-value < 0.05) 84,349 SNPs (Table 1) detected in the Labadorf dataset
as shown in Figure 3. We included visualization of the APOE gene variants in Figure 3 due to its
importance in neurodegenerations, Alzheimer’s Disease in particular. APOE genetic variants also affect
human longevity due to the transport of lipids and risks associated with cardiovascular diseases [38].
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Figure 3. Manhattan plot visualization of SNPs found significant (p-value < 0.05) in regions near
HTT, sortilins and APOE in the Labadorf 2015 dataset. Some of the genes were located in the same
chromosome (HTT and SORCS2 on chromosome 4, SORCS1 and SORCS3 on chromosome 10). When
the chromosome was identical, significant SNPs were counted as SNPs located 1,000,000 bp upstream
and downstream the gene border coordinates. The level of significance (negative log of p-value, y
axis) of SNPs identified near the sortilin genes suggested that the genetic variation in sortilins have a
significant impact on the Huntington’s disease (HD) pathology in this dataset.
Total SNPs detected between HTT and SORCS2 on chromosome 4 (11746 SNPs, Supplementary
Materials Table S6) were approximately 5X more SNPs than the region between SORCS1 and SORCS3
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genes on chromosome 10 (1976 SNPs, Supplementary Materials Table S6). This is in agreement with
the notion of the biological importance of the HTT locus as the Mendelian causative mutation of
the HD pathology. Compared to the APOE locus which is highly polymorphic due to its activity in
lipid metabolism, HTT carried at least 5X more SNP mutations than APOE (APOE carried 1863 total
SNPs in its vicinity) (Figure 3, Supplementary Materials Table S6). We detected 665 SNPs significantly
associated with HD in the vicinity of the HTT and sortilins genes (Supplementary Materials Table S6).
Positions, alleles, allele frequencies and p-values of 665 SNPs between the HTT and sortilins genes
significantly associated with HD are indicated in Supplementary Materials Table S7.
3.2. mHTT Affects Pathways Important for Immunological Function
By interrogating datasets analyzed for transcriptomic regulation and presence of SNPs associated
with mHTT in specific genomic regions known to be involved with Type 1 and Type 2 Diabetes,
we found that genes from the MHC/HLA locus, regarded as T1D markers [39], were down-regulated
in human cells expressing mHTT in the HD iPSC Consortium dataset (HLA-B) (Figure 2C). MHC/HLA
genes are responsible for the presentation of processed antigens to T-cells, and the activation of adaptive
immune response, as the gene expression is turned on after a virus or bacterial infection or tumor
mutation of proteins [40]. Figure 2C also shows that sortilin SORL1 and several tetraspanins are
modulated by HD in the HD iPSC Consortium dataset. SORL1 gene expression was down-regulated
to approximately a third of the control values, and reached statistical significance (Supplementary
Table S3). Other sortilins showed a similar trend, but not significance in the RNA-Seq analysis
(Supplementary Table S3). The HLA-B gene showed a decrease in the gene expression average of more
than 50X in the HD iPSC Consortium dataset (Supplementary Table S3).
The trend in the expression of the SORL1 gene in human was opposite to the pattern of the protein
expression of the SORCS1 gene observed in ST14 rat cells, in that the SORCS1 protein was up-regulated
by almost 2X (for the quantification of protein bands shown on Figure 2A, see Supplementary Materials
Figure S2 and Supplementary Table S5) in ST14A cells. These observations are based on the R package
DESeq2 analysis [41] that we performed on the datasets, which was different than that performed
by Labadorf et al. The SORCS1 gene in ST14A cells was also up-regulated in the DESeq2 RNA-Seq
analysis (Supplementary Table S4). In human datasets, sortilins showed a trend to be down-regulated
in the HD iPSC Consortium dataset (Figure 2C, Supplementary Table S3), in the Labadorf dataset
(Supplementary Table S6) and in the Lin 2016 dataset (Supplementary Table S7). However, the DESeq2
analysis was only detected as statistically significant, the difference in the expression levels of the
SORL1 gene in the HD iPSC Consortium dataset (Figure 2C), suggesting a gene expression influence of
mHTT on SORL1 similar to the trend detected previously in the AD for this receptor of Apolipoprotein
E [42,43]. These findings suggest a need in characterization of gene expression alterations related to
the immune function of sortilins in HD.
3.3. Validation of GATK/GWAS DNA Variants Identification by Pyrosequencing Methodology
To validate the GATK/GWAS pipeline and aiming to establish the presence of an SNP as the
result of RNA or DNA mutation, we performed a pyrosequencing detection of SORCS1 SNPs in
DNA extracted from ST14A cells carrying HTT and mHTT. To assess whether reads spanning SNPs
loci in mutant cells were the result of cell population heterogeneity or clonal expansion of the SNP,
we analyzed single cell data previously acquired in our lab from the same ST14A cells. Figure 4A
shows the Integrative Genome Viewer (IGV) visualization of reads spanning the loci of the detected
SNP. Figure 4B shows pyrosequencing results with mutation identified in genomic DNA.
Since the T allele was present in both the IGV visualization and DNA samples interrogated by
pyrosequencing, we conclude that the variant was a DNA variant rather than a SORCS1 mRNA variant.
This result confirmed that this SNP mutation in SORCS1 was identical to the mutation detected by the
GATK/GWAS pipeline using ST14A mRNA molecules, a C > T DNA substitution (Figure 4B).
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3.4. Sortilin and HTT SNPs Identified by GATK/GWAS Pipeline of RNA-Seq Datasets of Human Origin Are in
Linkage Disequilibrium
We interrogated 166 SNPs reported in other studies about their presence in the Labadorf dataset.
The Supplementary Table S2 shows SNPs identified in this GWAS study. 48 SNPs were present in the
Labadorf dataset, indicating a detection rate close to 30% of well-documented publicly available sortilins
SNPs in our study. Not necessarily all 48 SNPs had a significant p-value suggestive of association
with HD (Supplementary Table S2). However, important genetic variants previously detected in
studies associated with Alzheimer’s Disease were associated with HD (Supplementary Table S2,
p-values < 0.05). Results shown in Supplementary Table S2, although associated with HD (those with
p-values < 0.05) revealed that few sortilins SNP variants were in Linkage with HD (Supplementary
Material Figure S3). Therefore, we investigated Linkage patterns unique to our GATK/GWAS dataset
using the 665 SNPs shown in Figure 3 as associated with HD. A complete list of SNP variants per
gene and identity of the 665 significant SNPs in HTT and sortilins genes are shown in Supplementary
Materials Tables S8 and S9. After manually checking for the correlation of SNP position inheritance in
the control and cases of HD, haplotype maps of the Linkage Disequilibrium analysis involving HTT,
SORT1, SORL1, SORCS1, 2 and 3 SNPs variants are shown in Figure 5.
Linkage patterns observed in the Labadorf dataset on Figure 5 were in agreement with the Linkage
pattern observed in Lin 2016 (Supplementary Materials Figure S4). In both datasets, a continuous
haplotype block including SNP Chr1:109950858 (indicated in the red square in Figure 5), upstream of
SORT1 is in association with another haplotype block in region Chr4:3236883-3238643 near HTT in HD
cases, but not in controls of both Labadorf and Lin datasets (Figure 5, Supplementary Materials Figure
S4). Genes, positions and p-values of SNPs associated with HD shown in Figure 5 are indicated in
Supplementary Materials Table S10.
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4. Discussion
Previously, we reported on the modulation in the expression of glucose transporters GLUT1 and
GLUT4, and sortilin SORCS1 by mHTT in the ST14A cells, suggesting that mechanisms of insulin release
and insulin sensitivity were affected in human HD by means of sortilin genes [19]. The identification
of these genes in the HD pathology may be useful for therapeutic interventions that may include the
CRISPR/Cas9 gene editing or small drug inhibition of such genes. Sortilin SORCS1 was described as a
potential target in obesity. Sortilins are responsible for protein-protein interaction, internalization and
sorting of proteins between the trans-Golgi network and endosomes using the retromer complex [14].
Given this role in cells, we hypothesized that sortilin plays a role in the release of exosome vesicles.
To evaluate biological mechanisms of SORCS1, we are currently building a knock-out model of the
SORCS1 ST14A cells using CRISPR/Cas9 gene editing. We found non-coding variants in introns 1
and 2 of sortilin genes, including SORCS1, associated with HD in the human and in rat (Figure 1).
This observation suggests that variants could affect the interaction of sortilins genomic sequence
with proteins involved in their expression (Figures 1–3 and 5). These results are in agreement with
findings of Reitz et al., because these authors report on genetic variants located in introns 1 and 2 of
SORCS1, associated with Alzheimer’s Disease [15]. We also found a total of 11 SNPs, three of which are
significantly associated with HD, in common with SNPs observed by Reitz et al. 2013. All SNPs were
found in the non-coding regions of sortilins, (significant SNPs, p-value < 0.05: SORL1, Chr11:121439665;
SORCS1, Chr10:108706022 and SORCS2, Chr4:7733843) (Figure 1). SORCS1 mutations located in intron
2, between exons that encode the VPS10P sorting domain (Figure 1). These SNPs are therefore common
to HD and AD, suggesting that sortilins play biological roles in both AD and HD (Figure 1). We are
confident about these results because the number of significant SNPs associated with HD was small
compared to the total number of SNPs identified by the present GATK/GWAS pipeline (less than 5%
in all datasets as shown in Table 1). Furthermore, we confirmed that the mutations detected by this
GATK/GWAS pipeline were present in the genomic DNA derived from the ST14A cells using the
pyrosequencing assay, ruling out the possibility of mRNA variation (Figure 4A).
The Labadorf group also reported modulation of sortilin SORCS3 by mHTT in their Supplementary
Materials [28]. We observed that protein levels of sortilin SORCS1 were up-regulated in the ST14A
cells (Figure 2A), suggesting modification in the normal subcellular traffic between intracellular
organelles and plasma-membrane, as expected from cellular roles of sortilins [14,17]. Vázquez reported
on the involvement of sortilins in the maturation of phagosomes in the process of phagocytosis of
Mycobacterium tuberculosis [17]. In order to display peptides derived from this parasite in the MHC/HLA
class II complex, endosomal and lysosomal enzymes need to be delivered in sequence (sorted) into the
phagosome which contains the parasite proteins that will ultimately generate the parasite antigens [17].
Adaptor proteins are also implicated in the receptor-ligand transport of sortilins via clathrin-coated
vesicles to endosomes. Once cargo is released, induced by the low-pH environment [44], the retrograde
transport of sortilin from endosome to trans-Golgi network depends on the sortilin interaction with the
retromer complex [14,17]. Therefore, results shown in Figures 1–3 and 5 suggest that mHTT affects the
expression or associate with genetic variants of sortilins in ST14A cells and human individuals. This is
significant as it establishes a direct connection between vesicle traffic towards phagosome maturation
for innate and adaptive immune responses and variants of sortilins involved in the process (Figure 3,
Figure 5 and Supplementary Table S3). A further investigation of sortilins, tetraspanins and HLA/MHC
genes, may lead to the understanding of the involvement of HTT and mHTT in the release of cellular
vesicles, including exosomes, and how this might affect immunological pathways in diseases such as
HD, diabetes and cancer.
One study reported an association of celiac disease (CE), a condition thought to primarily involve
MHC/HLA genes, with SORCS1 variants [45]. It is not surprising to find vesicle trafficking associated
with defects in the HLA/MHC loci from the perspective of sortilins affecting vesicle trafficking in HD
brought by our study. Before identification of mHTT as the cause of HD, one hypothesis was that the
HLA/MHC loci were potential contributors or the only cause of HD. Consistent with this hypothesis,
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attempts were performed to assess the involvement of the HLA/MHC locus in the etiology of the
Huntington’s Disease [46,47]. Although some association was initially reported, it did not hold true
after scrutiny of statistical correction [46]. We observed several of the HLA/MHC rat genes with their
expression influenced by mHTT in ST14A cells (data not shown). We are currently investigating the
involvement of MHC/HLA genes in our ST14A HD cell model.
Our results add to the growing body of knowledge of sortilins as proteins that affect processing of
antigens in autoimmunity and other functions related to the immune system by providing evidence
that gene expression or genetic diversity of sortilin and MHC/HLA genes are associated with mHTT in
HD (Figures 1–3 and 5; Supplementary Materials Table S3). These findings contribute to an improved
understanding on the control of traffic of glucose receptors, insulin and Alzheimer’s Disease proteins
in the trans-Golgi network, the endosome and the plasma-membrane in normal and HD conditions,
using models of HD described in this report (Figures 1–5). We showed that mHTT is associated with
increased protein expression of sortilin SORCS1 in ST14A cells (Figure 2A), in agreement with our
previous report for mRNA molecules of SORCS1 and that there exists allele association (also known as
Linkage Disequilibrium) of regions near SORT1, SORL1, SORCS1, SORCS2 and SORCS3 with gene
variants in the region of HTT gene specifically in human HD cases (Figure 5). Eleven sortilins SNPs
previously detected by Reitz et al. (2013), who investigated the involvement of SORCS1 variants with
AD, were detected in our study (Supplementary Table S2) [14–16]. It is important to contrast the
number of individuals involved in many GWAS studies to the number of HD cases reported here
(Reitz 2013 individuals: n = 11,840 cases and 10,931 controls; Labadorf dataset 2015: n = 20 cases and
49 controls). Due to the sample size, more genetic variability is associated with the design of the Reitz
group, which helps explain the low number of positions identified in common between the Labadorf
and Reitz studies. Some of the SNP variants associated with HD were reported in Alzheimer’s and
cardiovascular diseases GWASs (Supplementary Table S2).
5. Conclusions
We present evidence of the association between the mHTT and genes of critical biological processes
in neurodegenerative diseases, diabetes and cancer in rat and human RNA-Seq datasets. The genetic
association of VPS10P (sortilins) variants with HTT variants in HD cases has also been established
in this work. Genetic variance of the HLA/MHC loci in human and rat samples deserve further
investigation, given the association with the mHTT shown in human and rat datasets. We hypothesize
the existence of an allele association between sortilins and HLA/MHC genes. We envision sortilins
and HLA/MHC proteins as potential therapeutic targets in cancer, diabetes, and neurodegenerative
diseases, by modulation of antigen processing and immune response mechanisms in these diseases.
In addition, our results further validate the rat ST14A cells as a model of human HD.
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